Abstract
Aquaglyceroporin-2 is a known determinant of melarsoprol-pentamidine cross-resistance in Trypanosoma brucei brucei laboratory strains. Recently, chimerization at the AQP2-AQP3 tandem locus was described from melarsoprol-pentamidine cross-resistant Trypanosoma brucei gambiense isolates from sleeping sickness patients in the Democratic Republic of the Congo. Here, we demonstrate that reintroduction of wild-type AQP2 into one of these isolates fully restores drug susceptibility while expression of the chimeric AQP2/3 gene in aqp2-aqp3 null T. b. brucei does not. This proves that AQP2-AQP3 chimerization is the cause of melarsoprol-pentamidine cross-resistance in the T. b. gambiense isolates.
| Original language | English |
|---|---|
| Pages (from-to) | 65-68 |
| Number of pages | 4 |
| Journal | International Journal for Parasitology: Drugs and Drug Resistance |
| Volume | 5 |
| Issue number | 2 |
| DOIs | |
| Publication status | Published - 1 Aug 2015 |
| Externally published | Yes |
Keywords
- Aquaporin
- Drug resistance
- Human African trypanosomiasis
- Melarsoprol
- Pentamidine
- Reverse genetics
- Sleeping sickness
- Trypanosoma brucei gambiense